Kamada (KMDA) Current Deferred Revenue (2012 - 2026)
Kamada (KMDA) reported Current Deferred Revenue of $67000.0 for Q1 2026, down 67.32% on a YoY basis from $205000.0 in Q1 2025, and down 93.44% quarter-over-quarter from $1.0 million in Q3 2025.
Kamada (KMDA) Current Deferred Revenue (2012 - 2026) Analysis & Trends
Kamada has reported Current Deferred Revenue for 15 years, with the latest figure at $67000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Revenue fell 67.32% year-over-year to $67000.0; the trailing twelve-month figure through Mar 2026 stood at $67000.0 (down 67.32% YoY), and the FY2024 full-year result was $171000.0, up 15.54% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $67000.0, down from $1.0 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $1.0 million in Q3 2025, with the low at $40.0 in Q3 2022.
- Historically, Current Deferred Revenue has averaged $128278.7 across 5 years, with a median of $40000.0 in 2022.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue plunged 100.0% — and 2023, when it soared 37400.0%.
- Kamada's Current Deferred Revenue stood at $35000.0 in 2022, then jumped by 322.86% to $148000.0 in 2023, then climbed by 15.54% to $171000.0 in 2024, then surged by 497.66% to $1.0 million in 2025, then plunged by 93.44% to $67000.0 in 2026.
- The last three Current Deferred Revenue figures came in at $67000.0 (Q1 2026), $1.0 million (Q3 2025), and $177000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 177,000.00 |
| Mar 31, 2025 | 205,000.00 |
| Dec 31, 2024 | 171,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 148,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 419.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 40.00 |
| Jun 30, 2022 | 40,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Dec 31, 2021 | 40,000.00 |
| Sep 30, 2021 | 3.58 Mn |
| Jun 30, 2021 | 3.03 Mn |
| Mar 31, 2021 | 2.53 Mn |